Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. We show 60 historical shares outstanding datapoints in our PODD shares outstanding history coverage, used to compute PODD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PODD market cap history over the course of time is important for investors
interested in comparing PODD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PODD versus a peer is one thing; comparing
PODD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PODD can fluctuate over the course of history.
With this page we aim to empower investors researching PODD by allowing them to research the PODD market cap history. |
Free PODD Email Alerts:
Video: The Importance of Market Cap
